Sleep-disordered breathing in newborn mice heterozygous for the transcription factor Phox2b

Estelle Durand1, Stéphane Dauger, Alexandre Pattyn

  • 1INSERM U676, Hôpital Robert-Debré, 48 Boulevard Sérurier, 75019 Paris, France.

Abstract

Insights

Newborn mice with a Phox2b gene deletion exhibited significant sleep-disordered breathing, mirroring a key feature of Central Congenital Hypoventilation Syndrome (CCHS). This research provides a valuable model for studying CCHS in infants.

Area of Science:

  • Genetics
  • Neuroscience
  • Respiratory Physiology

Background:

  • Central Congenital Hypoventilation Syndrome (CCHS) is a rare, inherited disorder affecting breathing regulation during sleep.
  • Mutations in the Phox2b homeobox gene are frequently identified in CCHS patients.

Purpose of the Study:

  • To investigate if heterozygous targeted deletion of the Phox2b gene in newborn mice results in sleep-disordered breathing.
  • To establish a potential animal model for studying CCHS.

Main Methods:

  • Breathing patterns were assessed in 5-day-old wild-type and Phox2b mutant mice using whole-body plethysmography.
  • Sleep-wake states were classified through nuchal electromyography (EMG) and behavioral observation.

Main Results:

  • Mutant mice displayed approximately six times more total sleep apnea time compared to wild-type controls.
  • Ventilation during active sleep was significantly reduced by 21% in mutant pups.
  • No significant differences in apnea time or ventilation were observed during wakefulness between groups.

Conclusions:

  • Phox2b(+/-) mutant mice exhibit sleep-disordered breathing, partially modeling the primary characteristic of CCHS.
  • These findings suggest Phox2b plays a crucial role in respiratory control during sleep.
  • The mutant mouse model offers a platform for further investigation into CCHS pathogenesis and potential therapies.

Related Concept Videos